Kazuo Nishimura Selected Research

Kazuo Nishimura Research Topics

Disease

58	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2002
39	Neoplasms (Cancer) 01/2024 - 06/2002
29	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 07/2002
20	Neoplasm Metastasis (Metastasis) 05/2023 - 11/2002
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 07/2005
7	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023 - 10/2002
7	Lymphatic Metastasis 09/2021 - 10/2006
6	Disease Progression 01/2022 - 10/2006
5	Testicular Neoplasms (Testicular Cancer) 11/2023 - 10/2002
5	Carcinoma (Carcinomatosis) 09/2017 - 03/2002
4	Pain (Aches) 01/2024 - 11/2002
4	Anemia 01/2023 - 01/2008
4	Infections 04/2021 - 10/2004
4	Kidney Neoplasms (Kidney Cancer) 04/2021 - 06/2007
4	Hemorrhage 08/2018 - 04/2006
3	Hepatitis 01/2024 - 09/2021
3	Thrombocytopenia (Thrombopenia) 07/2016 - 11/2013
3	Carcinoma in Situ 03/2010 - 06/2002
2	Abdominal Pain (Pain, Abdominal) 01/2024 - 03/2002
2	Renal Insufficiency (Renal Failure) 04/2023 - 06/2003
2	Lung Abscess 04/2022 - 05/2014
2	Pneumonia (Pneumonitis) 01/2022 - 09/2021
2	Melanoma (Melanoma, Malignant) 05/2021 - 04/2021
2	Exanthema (Rash) 01/2021 - 11/2011
2	Communicable Diseases (Infectious Diseases) 05/2020 - 09/2015
2	Lymphoma (Lymphomas) 02/2020 - 06/2007
2	Margins of Excision 01/2017 - 04/2012
2	Pleural Effusion (Pleural Effusions) 10/2016 - 07/2002
2	Urinary Tract Infections (Urinary Tract Infection) 09/2015 - 03/2002
2	Insulin Resistance 06/2015 - 01/2005
2	Brain Neoplasms (Brain Tumor) 01/2014 - 11/2009
2	Seminoma 01/2010 - 09/2009

Drug/Important Bio-Agent (IBA)

19	AndrogensIBA 12/2023 - 03/2002
10	Docetaxel (Taxotere)FDA Link 05/2023 - 01/2008
9	Hormones (Hormone)IBA 12/2023 - 11/2002
8	NivolumabIBA 01/2023 - 07/2020
7	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 10/2006
7	enzalutamideIBA 05/2022 - 01/2016
7	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 11/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2008
6	Axitinib (AG 013736)IBA 01/2024 - 10/2016
6	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2021
6	Sorafenib (BAY 43-9006)FDA Link 09/2018 - 07/2011
5	Androgen Receptors (Androgen Receptor)IBA 05/2023 - 02/2002
5	Sunitinib (Sutent)FDA Link 07/2020 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 07/2015 - 03/2002
4	Tyrosine Kinase InhibitorsIBA 03/2023 - 01/2016
4	Everolimus FDA Link 07/2020 - 11/2013
3	Radium-223IBA 01/2024 - 01/2021
3	pembrolizumabIBA 01/2024 - 01/2020
3	Therapeutic UsesIBA 12/2023 - 03/2022
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2023 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 11/2002
3	InterferonsIBA 10/2016 - 04/2013
3	C-Reactive ProteinIBA 07/2016 - 10/2004
3	NF-kappa B (NF-kB)IBA 01/2008 - 06/2006
3	Messenger RNA (mRNA)IBA 06/2005 - 03/2002
2	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 04/2013
2	Gemcitabine FDA Link 04/2023 - 11/2020
2	nedaplatinIBA 04/2023 - 06/2007
2	cabozantinibIBA 03/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2022
2	cabazitaxel FDA Link 01/2023 - 02/2020
2	taxaneIBA 01/2023 - 01/2022
2	IpilimumabIBA 10/2022 - 04/2022
2	abirateroneIBA 05/2022 - 01/2022
2	olaparibIBA 05/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 05/2014
2	SteroidsIBA 04/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 03/2002
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2015 - 01/2005
2	Insulin (Novolin)FDA Link 06/2015 - 01/2005
2	Dihydrotachysterol (AT 10)IBA 07/2014 - 06/2013
2	Estramustine FDA Link 02/2014 - 08/2013
2	Interferon-alpha (Interferon Alfa)IBA 09/2012 - 04/2009
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2010 - 02/2009
2	Conditioned Culture MediaIBA 01/2010 - 06/2005

Therapy/Procedure

60	Therapeutics 01/2024 - 03/2002
26	Drug Therapy (Chemotherapy) 04/2023 - 03/2002
24	Castration 01/2024 - 08/2010
14	Nephrectomy 01/2024 - 03/2002
13	Radiotherapy 12/2023 - 10/2006
11	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 01/2004
4	Aftercare (After-Treatment) 01/2024 - 01/2005
4	Molecular Targeted Therapy 07/2016 - 06/2006
3	Drug Tapering 01/2024 - 11/2011
3	Immunotherapy 04/2022 - 12/2012
3	Adrenalectomy 04/2020 - 04/2006
3	Oral Administration 01/2019 - 06/2007
3	Nephroureterectomy 09/2017 - 06/2002
3	Metastasectomy 12/2011 - 07/2010
3	Orchiectomy (Orchidectomy) 09/2009 - 07/2006
2	Operative Surgical Procedures 01/2021 - 09/2016
2	Lymph Node Excision (Lymph Node Dissection) 03/2020 - 10/2002
2	Cystectomy 09/2017 - 07/2012
2	Brachytherapy 01/2017 - 07/2006
2	Operative Time 12/2013 - 01/2008
2	Adjuvant Chemotherapy 07/2013 - 10/2012